Lifecore Biomedical, Inc. (LFCR): Depreciation & Amortization
$8.03M
Year ended 2025-05-25
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-05-25 | $8.03M | +0.9% | 2025-08-07, From 2024-05-27 |
| 2024-05-26 | $7.95M | n/c | 2025-08-07, From 2023-05-29 |
| 2023-05-28 | $13.18M | -27.0% | 2024-08-26, From 2022-05-30 |
| 2022-05-29 | $18.06M | -9.1% | 2024-08-26, From 2021-05-31 |
| 2021-05-30 | $19.87M | +5.5% | 2024-03-20, From 2020-06-01 |
| 2020-05-31 | $18.84M | +23.7% | 2023-03-16, From 2019-05-27 |
| 2019-05-26 | $15.23M | +22.7% | 2021-07-29, From 2018-05-28 |
| 2018-05-27 | $12.41M | +16.2% | 2020-08-14, From 2017-05-29 |
| 2017-05-28 | $10.68M | +13.6% | 2019-08-01, From 2016-05-30 |
| 2016-05-29 | $9.39M | +32.5% | 2018-08-09, From 2015-06-01 |
| 2015-05-31 | $7.09M | -0.3% | 2018-03-15, From 2014-05-26 |
| 2014-05-25 | $7.11M | -2.5% | 2016-08-01, From 2013-05-27 |
| 2013-05-26 | $7.29M | +29.8% | 2015-07-31, From 2012-05-28 |
| 2012-05-27 | $5.62M | +5.8% | 2014-08-01, From 2011-05-30 |
| 2011-05-29 | $5.31M | +57.9% | 2013-08-07, From 2010-05-31 |
| 2010-05-30 | $3.36M | n/a | 2012-08-08, From 2009-06-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.03M | +0.9% |
| Xencor Inc (XNCR) | 2025-12-31 | $10.51M | -13.2% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $2.48M | +60.2% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $1.07M | -12.6% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $7.17M | -4.9% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | $307.0K | -6.7% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $2.31M | -7.1% |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $4.05M | -36.5% |
| Liquidia Corp (LQDA) | 2025-12-31 | $1.53M | -30.5% |
Compare LFCR, XNCR, GYRE, ELTP side by side · Screen every company in Pharmaceutical Preparations ↗